UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

The Journal of infectious diseases, 2013-01, Vol.207 (2), p.213-222

2013

Volltextzugriff (PDF)

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

PLoS medicine, 2010-08, Vol.7 (8), p.e1000321

2010

Volltextzugriff (PDF)

Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control

Journal of virology, 2023-01, Vol.97 (1), p.e0125422-e0125422

2023

Volltextzugriff (PDF)

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV

Nature communications, 2021-06, Vol.12 (1), p.3922-3922, Article 3922

2021

Volltextzugriff (PDF)

Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice

Molecular therapy. Nucleic acids, 2018-09, Vol.12, p.275-282

2018

Volltextzugriff (PDF)

Assessing the associations between known genetic variants and substance use in people with HIV in the United States

PloS one, 2023-10, Vol.18 (10), p.e0292068-e0292068

2023

Volltextzugriff (PDF)

Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in People With Human Immunodeficiency Virus: A Tale of Two Pandemics

The Journal of infectious diseases, 2023-04, Vol.227 (7), p.835-837

Jacobson, Jeffrey M

2023

Volltextzugriff (PDF)

Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.1831-1842

2011

Volltextzugriff (PDF)

Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection

Frontiers in immunology, 2023-09, Vol.14, p.1231087

2023

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.450-457

2009

Volltextzugriff (PDF)

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection

PLoS pathogens, 2013-10, Vol.9 (10), p.e1003658-e1003658

2013

Volltextzugriff (PDF)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients

PloS one, 2016-05, Vol.11 (5), p.e0155382

2016

Volltextzugriff (PDF)

Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton

Bone (New York, N.Y.), 2006-11, Vol.39 (5), p.1059-1066

2006

Volltextzugriff (PDF)

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

PloS one, 2013-12, Vol.8 (12), p.e83514-e83514

2013

Volltextzugriff (PDF)

Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics

AIDS research and human retroviruses, 2018-11, Vol.34 (11), p.950-960

2018

Volltextzugriff (PDF)

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV

Cancer medicine (Malden, MA), 2023-05, Vol.12 (9), p.11010-11019

2023

Volltextzugriff (PDF)

Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study

International journal of infectious diseases, 2021-01, Vol.102, p.45-52

2021

Volltextzugriff (PDF)

Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults

The Journal of infectious diseases, 2008-11, Vol.198 (9), p.1345-1352

2008

Volltextzugriff (PDF)

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4137-4142

2010

Volltextzugriff (PDF)

Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody

The Journal of infectious diseases, 2010-05, Vol.201 (10), p.1481-1487

2010

Volltextzugriff (PDF)

Effective and targeted latency reversal in CD4 + T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection

Emerging microbes & infections, 2024-12, Vol.13 (1), p.2327371-2327371

2024

Volltextzugriff (PDF)

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity

PloS one, 2016-04, Vol.11 (4), p.e0150835-e0150835

2016

Volltextzugriff (PDF)

Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3466

2022

Volltextzugriff (PDF)

Antiretroviral Drugs Regulate Epigenetic Modification of Cardiac Cells Through Modulation of H3K9 and H3K27 Acetylation

Frontiers in cardiovascular medicine, 2021-04, Vol.8, p.634774-634774

2021

Volltextzugriff (PDF)

Sonographic diagnosis of spondylodiscitis in a young child

Pediatric radiology, 2024-05, Vol.54 (6), p.1049-1052

2024

Volltextzugriff (PDF)

1 – 25 von 648

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(603)
Mit Volltextzugriff
(525)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(646)
Japanisch
(69)
Hebräisch
(1)
Latein
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV

Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice

Assessing the associations between known genetic variants and substance use in people with HIV in the United States

Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in People With Human Immunodeficiency Virus: A Tale of Two Pandemics

Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection

Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection

Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients

Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV

Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study

Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults

Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody

Effective and targeted latency reversal in CD4 + T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity

Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone

Antiretroviral Drugs Regulate Epigenetic Modification of Cardiac Cells Through Modulation of H3K9 and H3K27 Acetylation

Sonographic diagnosis of spondylodiscitis in a young child

Suchergebnisse filtern